RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+8.44%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$5.25B
AUM Growth
+$5.25B
(+9.4%)
Cap. Flow
+$313M
Cap. Flow
% of AUM
5.95%
Top 10 Holdings %
Top 10 Hldgs %
53.61%
Holding
70
New
10
Increased
19
Reduced
1
Closed
8
Top Buys
| 1 |
Bruker
BRKR
|
$131M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$103M |
| 3 |
Intuitive Surgical
ISRG
|
$58.1M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$52.3M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$51.2M |
Top Sells
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$351M |
| 2 |
Ventyx Biosciences
VTYX
|
$46.5M |
| 3 |
Apyx Medical
APYX
|
$8.15M |
| 4 |
ALLK
Allakos
ALLK
|
$5.9M |
| 5 |
Castle Biosciences
CSTL
|
$5.87M |
Sector Composition
| 1 | Healthcare | 99.97% |
| 2 | Financials | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Immunocore
IMCR
$1.62B
| $362M | 6.88% | 6,029,633 +379,690 | +7% | +$22.8M |
|
2
Rocket Pharmaceuticals
RCKT
$354M
| $351M | 6.69% | 17,687,772 | – | – |
|
3
Alnylam Pharmaceuticals
ALNY
$58.5B
| $320M | 6.09% | 1,683,362 | – | – |
|
4
Axsome Therapeutics
AXSM
$6.05B
| $308M | 5.86% | 4,284,277 +503,422 | +13% | +$36.2M |
|
5
PTC Therapeutics
PTCT
$3.92B
| $294M | 5.6% | 7,235,196 +141,898 | +2% | +$5.77M |
|
|
6
Ultragenyx Pharmaceutical
RARE
$2.89B
| $249M | 4.75% | 5,405,089 +1,134,093 | +27% | +$52.3M |
|
7
Masimo
MASI
$7.59B
| $247M | 4.7% | 1,501,493 | – | – |
|
8
Acadia Pharmaceuticals
ACAD
$4.38B
| $234M | 4.46% | 9,783,249 +1,540,385 | +19% | +$36.9M |
|
9
Penumbra
PEN
$10.6B
| $232M | 4.41% | 673,371 | – | – |
|
|
10
Bruker
BRKR
$5.16B
| $219M | 4.16% | 2,959,603 +1,772,261 | +149% | +$131M |
|
11
argenx
ARGX
$43.6B
| $188M | 3.58% | 482,195 | – | – |
|
12
Establishment Labs
ESTA
$1.2B
| $171M | 3.26% | 2,494,138 +105,000 | +4% | +$7.2M |
|
|
MRTX
13
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $162M | 3.08% | 4,472,985 +829,871 | +23% | +$30M |
|
14
Thermo Fisher Scientific
TMO
$186B
| $151M | 2.88% | 290,334 | – | – |
|
15
Protagonist Therapeutics
PTGX
$3.67B
| $150M | 2.85% | 5,415,514 +814,715 | +18% | +$22.5M |
|
16
Natera
NTRA
$23.1B
| $127M | 2.42% | 2,611,783 | – | – |
|
17
Vericel Corp
VCEL
$1.83B
| $124M | 2.35% | 3,291,873 | – | – |
|
18
Celldex Therapeutics
CLDX
$1.47B
| $118M | 2.24% | 3,463,201 +378,986 | +12% | +$12.9M |
|
|
AVDL
19
Avadel Pharmaceuticals
AVDL
$1.43B
| $112M | 2.14% | 6,810,641 +1,068,702 | +19% | +$17.6M |
|
|
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $103M | 1.96% | +1,000,000 | New | +$103M |
|
21
Cytokinetics
CYTK
$4.23B
| $84M | 1.6% | 2,574,198 | – | – |
|
22
10x Genomics
TXG
$1.74B
| $81.7M | 1.56% | 1,462,956 +533,670 | +57% | +$29.8M |
|
23
Avidity Biosciences
RNA
$5.99B
| $74.2M | 1.41% | 6,689,789 +302,611 | +5% | +$3.36M |
|
24
Illumina
ILMN
$15.8B
| $70.5M | 1.34% | 376,250 | – | – |
|
|
25
Intuitive Surgical
ISRG
$170B
| $58.1M | 1.11% | +170,000 | New | +$58.1M |
|